Effect of carbidopa on the excretion of sodium, dopamine, and ouabain-like substance in the rat.
The effect of carbidopa, a competitive inhibitor of dopamine synthesis on the excretion of sodium, dopamine (DA), and endogenous sodium transport inhibitor (ESTI), was examined in rats on normal and high salt diets for 7 days. ESTI activity was measured (1) as ouabain-like substance (OLS) by radioimmunoassay using an antibody raised against ouabain, (2) by inhibition of purified Na+,K+-ATPase activity (ATPI), and (3) as digoxin-like substance (DLS) using a commercial digoxin assay. The OLS immunoassay was validated against rubidium transport studies. High salt diet caused an increase in OLS and ATPI but not DLS. Sodium excretion in rats on normal sodium intake was not affected by carbidopa treatment but was significantly lower in the high sodium diet group during the first 5 days of the study. In the low salt group, carbidopa treatment caused significant increases in OLS. We conclude that ESTI (measured as OLS) and DA are important in the natriuresis of salt loading.
Ho
C S
CS
Department of Chemical Pathology, Prince of Wales Hospital, Shatin, NT, Hong Kong.
Butt
A
A
Semra
Y K
YK
Swaminathan
R
R
D000704:Analysis of Variance; D000818:Animals; D002230:Carbidopa / Q000494:pharmacology*; D003404:Creatinine / Q000652:urine; D004077:Digoxin / Q000652:urine; D004298:Dopamine / Q000652:urine*; D008297:Male; D010042:Ouabain / Q000652:urine*; D010455:Peptides / Q000494:pharmacology / Q000652:urine*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D012964:Sodium / Q000652:urine*; D012982:Sodium, Dietary; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors
D010455:Peptides; D012982:Sodium, Dietary; C029311:serum sodium transport inhibitor; D010042:Ouabain; D004077:Digoxin; D012964:Sodium; D003404:Creatinine; D000254:Sodium-Potassium-Exchanging ATPase; D002230:Carbidopa; D004298:Dopamine